1-ethyl-2-benzimidazolinone has been researched along with Absence Seizure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forcelli, PA; Khandai, P; N'Gouemo, P | 1 |
| Anderson, NJ; Slough, S; Watson, WP | 1 |
2 other study(ies) available for 1-ethyl-2-benzimidazolinone and Absence Seizure
| Article | Year |
|---|---|
Activation of small conductance calcium-activated potassium channels suppresses seizure susceptibility in the genetically epilepsy-prone rats.
Topics: Action Potentials; Animals; Benzimidazoles; Epilepsy; Female; Male; Rats; Seizures; Small-Conductance Calcium-Activated Potassium Channels | 2020 |
In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant.
Topics: Animals; Anticonvulsants; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Levetiracetam; Male; Mice; Motor Activity; Pentylenetetrazole; Phenytoin; Pilocarpine; Piracetam; Seizures; Sensory Thresholds; Small-Conductance Calcium-Activated Potassium Channels | 2006 |